Executive Briefings | May 25, 2016
The Chain Continues – Value-Based Payment Moves To Devices & Pharma
We’ve seen the slow and steady growth of pay-for-value reimbursement models in the health care system. From Medicaid, the Medicare, to commercial payers – value-based care is the name of the game (see How Prepared Are Health & Human Service Provider Organizations For Value-Based Reimbursement? and Exactly Where Are We With Value-Based Reimbursement?). One of the big developments happened at the end . . .